Schubert & Co’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-260
Closed -$879 224
2023
Q1
$879 Hold
260
﹤0.01% 1246
2022
Q4
$931 Hold
260
﹤0.01% 1198
2022
Q3
$1K Hold
260
﹤0.01% 1017
2022
Q2
$1K Hold
260
﹤0.01% 1006
2022
Q1
$2K Hold
260
﹤0.01% 353
2021
Q4
$2K Buy
+260
New +$2.47K ﹤0.01% 315

Other funds holding SRTA

Schubert & Co's SRTA Position: Q2 2023 in Review

Schubert & Co sold out of Strata Critical Medical Inc (SRTA) in Q2 2023, closing a stake of 260 shares — an estimated $879 sold.

Schubert & Co first reported a position in SRTA in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q2 2023.

  • Schubert & Co reported no remaining Strata Critical Medical Inc position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 260 Strata Critical Medical Inc shares in Q2 2023, an estimated $879.
  • Schubert & Co first reported a position in Strata Critical Medical Inc in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Strata Critical Medical Inc position peaked at $2K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.